image credit: Vecteezy

Rentschler Biopharma to Begin Construction of New Multi-Product Commercial Manufacturing Facility

On Aug. 12, 2021, Rentschler Biopharma announced that it has broken ground at its new production site, adjacent to its existing Milford, Mass., site where it will build the Rentschler Biopharma Manufacturing Center US, a new facility that will add 22,000 ft2 of manufacturing cleanroom space and house four new 2000-L single-use bioreactors. The company expects the RBMC US to be operational in late 2023.

The facility is designed with upstream ballroom processing-size space for production flexibility and downstream processing suites equipped with buffer storage and preparation space.

Read More on Biopharm International